TV News LIES

Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. has said Dunkin’ and other companies will need to prove that their ingredients are safe, prompting Massachusetts Gov. Maura Healey (D) on Wednesday to reply back, “Come and take it.”

Kennedy, while at a rally at Brazos Hall last week in Austin, Texas, said, “We’re going to ask Dunkin’ Donuts and Starbucks, ‘Show us the safety data that show that it’s OK for a teenage girl to drink an iced coffee with 115 grams of sugar in it.'”

He added, as the audience applauded, “I don’t think they’re going to be able to do it.

“The reforms aim to ensure American foods follow the highest safety and nutritional standards globally,” MAHA Action, Kennedy’s nonprofit health advocacy group, said in a statement explaining Kennedy’s announcement.

More...

The Supreme Court on March 2 backed parents' right to be told if their child changes their name, or pronouns they're using in school, blocking California rules aimed at preventing teachers from outing transgender students to their parents.

"Under long-established precedent, parents − not the State − have primary authority with respect to 'the upbringing and education of children,'" the majority said in an unsigned opinion. "The right protected by these precedents includes the right not to be shut out of participation in decisions regarding their children’s mental health."

The court’s three liberal justices dissented from the decision to grant the parents' emergency request.

Justice Elena Kagan criticized the conservative majority for making a rushed decision about a case "raising novel legal questions and arousing strong views" that is at an early stage of litigation.

"The Court is impatient: It already knows what it thinks, and insists on getting everything over quickly," she wrote of the decision that came without the full rounds of briefing and oral arguments for cases.

More...

Since September, 16 major drug companies have inked deals with the Trump administration to lower prices. But in January — the time of year when pharmaceutical companies typically roll out price hikes — all 16 companies released higher list prices for some of their drugs.

The agreements, nicknamed "most favored nation" deals, were aimed at getting lower prices for American consumers and pushing other wealthy countries to pay higher prices for new drugs.

But drug companies, including the 16 that made deals, raised the prices of 872 brand-name drugs in the first two weeks of 2026, according to a new analysis by 46brooklyn, a drug price research firm.The drugs with price hikes included medicines to treat cancer, heart failure and Type 2 diabetes. The price of some COVID shots also went up.

"The real truth serum is what's happening in the marketplace after those deals occur," says Antonio Ciaccia, CEO of 46brooklyn, a nonprofit that tracks the list prices of prescription medications. "January is prime time for list price changes on brand-name drugs. So in examining where we are today, we're pretty much in line with the last few years."

More...

Dr. Kade Goepferd watched the Trump administration's moves on Thursday to ban gender-affirming care for transgender youth with "a mix of sadness and frustration."

Goepferd, who is the founder of Children's Minnesota Gender Health Program, says that for the medical community, nothing has changed about the evidence supporting gender-affirming care that could justify the government's actions.

"There's a massive propaganda and disinformation campaign that is selectively targeting this small population of already vulnerable kids and their families," Goepferd says.

Federal health officials said many times at Thursday's announcement that their actions were driven by science and evidence, not politics or ideology. They frequently praised a report published by the Department of Health and Human Services in November. It concluded that clinicians who provide medical care to help youth transition have failed their patients and emphasized the benefits of psychotherapy as an alternative.

More...

With subsidies for Affordable Care Act (ACA) health insurance set to expire, Americans who rely on them will probably switch to plans with lower monthly premiums and high deductibles or decide not to purchase any coverage, which will have a serious and damaging impact on the entire sector, according to healthcare policy experts.

The average amount ACA plan enrollees pay annually for premiums is estimated to more than double, from an average of $888 this year to $1,904 in 2026, according to a KFF analysis.

That will then have economic downstream effects, including for rural hospitals and people who have employer-sponsored health insurance, according to the experts.

With “a significant portion of people dropping their marketplace coverage and being uninsured, it doesn’t just impact them, it impacts everyone”, said Emma Wager, a senior policy analyst for KFF’s program on the Affordable Care Act (ACA).

More...

A California jury on Friday awarded $40m to two women who said Johnson & Johnson’s baby powder was to blame for their ovarian cancer.

The jury in Los Angeles superior court awarded $18m to Monica Kent and $22m to Deborah Schultz and her husband after finding that Johnson & Johnson knew for years its talc-based products were dangerous but failed to warn consumers.

Erik Haas, Johnson & Johnson’s worldwide vice-president of litigation, said in a statement the company plans to “immediately appeal this verdict and expect to prevail as we typically do with aberrant adverse verdicts”.

A spokesperson for the plaintiffs did not immediately respond to a request for comment.

Kent was diagnosed with ovarian cancer in 2014, according to court records. Schultz was diagnosed in 2018. Both women are California residents who say they used J&J’s baby powder after bathing for 40 years. Their treatments for ovarian cancer have involved major surgeries and dozens of rounds of chemotherapy, they testified at the trial.

In closing arguments that Reuters viewed on Courtroom View Network, Andy Birchfield, an attorney for the women, told the jury that Johnson & Johnson knew as far back as the 1960s that its product could cause cancer.

More...